相似文献
1
Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.
Bioinformatics. 2012 Jun 15;28(12):1555-61. doi: 10.1093/bioinformatics/bts168. Epub 2012 Apr 6.
2
Identifying cancer driver genes in tumor genome sequencing studies.
Bioinformatics. 2011 Jan 15;27(2):175-81. doi: 10.1093/bioinformatics/btq630. Epub 2010 Dec 17.
3
Driver gene mutations based clustering of tumors: methods and applications.
Bioinformatics. 2018 Jul 1;34(13):i404-i411. doi: 10.1093/bioinformatics/bty232.
4
Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.
BMC Bioinformatics. 2013 Dec 13;14:363. doi: 10.1186/1471-2105-14-363.
5
Comprehensive identification of mutational cancer driver genes across 12 tumor types.
Sci Rep. 2013 Oct 2;3:2650. doi: 10.1038/srep02650.
6
Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer.
Genome Med. 2019 Jul 26;11(1):49. doi: 10.1186/s13073-019-0659-1.
7
DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Am J Hum Genet. 2013 Sep 5;93(3):439-51. doi: 10.1016/j.ajhg.2013.07.003. Epub 2013 Aug 15.
8
Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Bioinformatics. 2017 Feb 15;33(4):483-490. doi: 10.1093/bioinformatics/btw662.
9
JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data.
Bioinformatics. 2012 Apr 1;28(7):907-13. doi: 10.1093/bioinformatics/bts053. Epub 2012 Jan 27.
10
Inferring Sequential Order of Somatic Mutations during Tumorgenesis based on Markov Chain Model.
IEEE/ACM Trans Comput Biol Bioinform. 2015 Sep-Oct;12(5):1094-103. doi: 10.1109/TCBB.2015.2424408.
引用本文的文献
1
A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity.
Cancers (Basel). 2024 Jul 8;16(13):2488. doi: 10.3390/cancers16132488.
2
HyperHMM: efficient inference of evolutionary and progressive dynamics on hypercubic transition graphs.
Bioinformatics. 2023 Jan 1;39(1). doi: 10.1093/bioinformatics/btac803.
3
A phylogenetic approach to inferring the order in which mutations arise during cancer progression.
PLoS Comput Biol. 2022 Dec 2;18(12):e1010560. doi: 10.1371/journal.pcbi.1010560. eCollection 2022 Dec.
4
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
BMC Bioinformatics. 2019 Dec 2;20(1):620. doi: 10.1186/s12859-019-3218-2.
5
Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach.
Int J Mol Sci. 2019 Oct 19;20(20):5190. doi: 10.3390/ijms20205190.
6
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations.
J Pathol. 2018 Sep;246(1):67-76. doi: 10.1002/path.5110. Epub 2018 Jul 31.
7
Somatic evolutionary timings of driver mutations.
BMC Cancer. 2018 Jan 18;18(1):85. doi: 10.1186/s12885-017-3977-y.
8
The evolution of tumour phylogenetics: principles and practice.
Nat Rev Genet. 2017 Apr;18(4):213-229. doi: 10.1038/nrg.2016.170. Epub 2017 Feb 13.
9
Age-related mutations and chronic myelomonocytic leukemia.
Leukemia. 2016 Apr;30(4):906-13. doi: 10.1038/leu.2015.337. Epub 2015 Dec 9.
10
An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.
PLoS Comput Biol. 2015 Sep 17;11(9):e1004350. doi: 10.1371/journal.pcbi.1004350. eCollection 2015 Sep.
本文引用的文献
1
Temporal dissection of tumorigenesis in primary cancers.
Cancer Discov. 2011 Jul;1(2):137-43. doi: 10.1158/2159-8290.CD-11-0028. Epub 2011 Jun 29.
2
Identifying cancer driver genes in tumor genome sequencing studies.
Bioinformatics. 2011 Jan 15;27(2):175-81. doi: 10.1093/bioinformatics/btq630. Epub 2010 Dec 17.
3
The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer?
J Clin Invest. 2010 Dec;120(12):4179-82. doi: 10.1172/JCI45406. Epub 2010 Nov 22.
4
Translational research in oncology: key bottlenecks and new paradigms.
Expert Rev Mol Med. 2010 Oct 7;12:e32. doi: 10.1017/S1462399410001638.
5
A mathematical framework to determine the temporal sequence of somatic genetic events in cancer.
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17604-9. doi: 10.1073/pnas.1009117107. Epub 2010 Sep 23.
6
Somatic mutations affect key pathways in lung adenocarcinoma.
Nature. 2008 Oct 23;455(7216):1069-75. doi: 10.1038/nature07423.
7
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13081-6. doi: 10.1073/pnas.0801523105. Epub 2008 Aug 22.
8
Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung.
Cancer Genet Cytogenet. 2008 Jul;184(1):31-7. doi: 10.1016/j.cancergencyto.2008.03.002.
9
Comparative lesion sequencing provides insights into tumor evolution.
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4283-8. doi: 10.1073/pnas.0712345105. Epub 2008 Mar 12.
10
The genomic landscapes of human breast and colorectal cancers.
Science. 2007 Nov 16;318(5853):1108-13. doi: 10.1126/science.1145720. Epub 2007 Oct 11.
Zotero 插件